性染色体异常无创产前DNA筛查的确诊率因确诊检测方法而异
基于超过90000例样本的回顾性研究,分析144例性染色体非整倍体(SCA)高风险病例,总体阳性预测值(PPV)为38.9%,单体X的PPV为29.0%。确诊检测方法影响PPV:羊膜腔穿刺29.5% vs 绒毛膜取样50.0%,差异由单体X驱动(绒毛膜取样54.6% vs 羊膜腔穿刺17.1%)。
要点
- 确诊方法影响PPV:绒毛膜取样50.0% vs 羊膜腔穿刺29.5%,差异由单体X驱动。
- 单体X的PPV在绒毛膜取样为54.6%,在羊膜腔穿刺为17.1%。
核心结论
- 异常cfDNA筛查SCA的PPV低,尤其是单体X,确诊率取决于确诊检测类型。
研究设计与样本
- 基于送至Cenata私营实验室并使用Harmony产前检测的样本的回顾性研究,研究人群包括144例SCA高风险病例。
主要发现
- cfDNA提示单体X、XXX、XXY和XYY的病例数分别为62例、37例、40例和5例。
- 112例(77.8%)SCA高风险女性选择产前核型分析。
- 在该组中,羊膜腔穿刺与绒毛膜取样评估核型时的PPV存在显著差异:29.5% vs 50.0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the positive predictive value (PPV) of cfDNA screening for sex chromosome aneuploidies (SCA) in a large series of over 90 000 patients. METHODS: Retrospective study based on samples that were sent to Cenata, a private laboratory which uses the Harmony Prenatal Test. The SCA high-risk results were stratified according to the method of diagnostic testing and according to karyotype result. RESULTS: The study population consisted of 144 cases. The CfDNA test indicated monosomy X, XXX, XXY, and XYY in 62, 37, 40, and 5 cases, respectively. The overall PPV was 38.9% (30.9-47.4), 29.0% (18.2-42.9) for monosomy X, 29.7% (15.9-47.9) for 47,XXX, 57.5% (40.9-73.0) for 47,XXY, and 80.0% (28.4-99.5) for 47,XYY). A total of 112 (77.8%) women with a high-risk result for SCAs opted for prenatal karyotyping. In this group, there were significant differences in the PPV if the karyotype was assessed by amniocentesis or by CVS: 29.5% vs 50.0%. This significant difference was driven by the monosomy X result which shows a significantly higher PPV in CVS (54.6% (23.4-83.3) vs 17.1% (6.6-33.6)). For the other SCAs, the differences were not significant. CONCLUSION: PPV of an abnormal cfDNA test for SCAs is low, particularly for monosomy X. The confirmation rate depends on the type of confirmatory test.
引用
- Lüthgens K, Grati FR, Sinzel M, et al. Confirmation rate of cell free DNA screening for sex chromosomal abnormalities according to the method of confirmatory testing. Prenat Diagn. 2020. PMID: 32804406. doi:10.1002/pd.5814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。